Five of these trials have shown superiority in reducing MACE compared to placebo, while all have confirmed the cardiovascular safety of GLP-1 RAs ( 4.3.1 Cardiovascular outcomes in GLP-1 RAs studies The ELIXA trial, which included 6068 patients, was the first to investigate the cardiovascular effects of GLP-1 RAs
Consider Switching to Tirzepatide Some people respond better to tirzepatide, which works on both GLP-1 & GIP receptors for enhanced weight loss and blood sugar control. Not all medications work the same for everyoneyour body might need a different approach
Clients often receive guidance on how to administer the injection, rotate injection sites to avoid irritation, and track their progress
Contact your GP if you experience persistent nausea preventing adequate intake, severe upper abdominal pain, inability to eat sufficiently, or signs of hypoglycaemia when combined with insulin or sulphonylureas
Have serious kidney or liver problems
My name is Isabelle, the medical aesthetician at YYC Botox, and I am happy to share my personal experience with you as someone getting botox in her late-20s for the first time and hopefully help you answer some burning questions